상세 보기
Journal of Cloud Computing
ISSN
E 2192-113X
출판사
Springer Science + Business Media
국가
ENGLAND
발행 상태
활성
데이터베이스 수록 정보
CiteScore 2014-2025 (12년)
DOAJ 2017-2025 (9년)
ESCI 2016-2018 (3년)
JCR 2018-2025 (8년)
SCIE 2018-2026 (9년)
Scopus 2012-2026 (15년)
SJR 2013-2020, 2022-2025 (12년)
전체 5건 중 1번부터 5번까지의 결과를 표시합니다.
2025
Article
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)
- Im, S. A. ;
- Park, K. ;
- Koh, J. ;
- Park, C. ;
- Jung, K. H. ;
- ... Park, I. H. ;
- 외 29명
- 2025-10
- ESMO Open
- ELSEVIER
Article
A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17) (vol 9, 103668, 2024)
- Kang, E. J. ;
- Yang, Y. ;
- Lee, S. ;
- Kim, Y. J. ;
- Lim, S. M. ;
- ... Choi, Y. J. ;
- 외 12명
- 2025-04
- ESMO Open
- ELSEVIER
2024
Article
Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18 (vol 8, 101588, 2023)
- Kim, M. ;
- Lee, J. L. ;
- Shin, S. J. ;
- Bae, W. K. ;
- Lee, H. J. ;
- ... Choi, Y. J. ;
- 외 7명
- 2024-11
- ESMO Open
- ELSEVIER
Article
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer
- Park, K. H. ;
- Loibl, S. ;
- Sohn, J. ;
- Park, Y. H. ;
- Jiang, Z. ;
- 외 26명
- 2024-05
- ESMO Open
- ELSEVIER
2023
Article
Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18
- Kim, M. ;
- Shin, S. J. ;
- Lee, J. L. ;
- Bae, W. K. ;
- Choi, Y. J. ;
- ... Park, K. H. ;
- 외 7명
- 2023-08
- ESMO Open
- ELSEVIER